FIELD: medicine.
SUBSTANCE: composition of an aqueous suspension for treating or preventing an inflammatory or infectious eye disease comprises nanoparticles of a macrolide antibiotic, in which nanoparticles have an average particle diameter of 300 nm or less, and 90 % diameter of 1500 nm or less, and which as surfactant contains polyoxyethylene hydrogenated castor oil (HCO), hydroxypropyl methyl cellulose (HPMC) or methylcellulose (MC) as a polymer thickener.
EFFECT: present invention relates to an aqueous suspension composition comprising nanoparticles of a macrolide antibiotic, and to use thereof.
7 cl, 7 dwg, 15 tbl, 19 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AQUEOUS SUSPENSION CONTAINING GLUCOCORTICOSTEROID NANOPARTICLES | 2016 |
|
RU2747803C2 |
| NANOPARTICLE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF EYE DISEASES OR CANCER | 2018 |
|
RU2797114C2 |
| PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS FOR THEIR PRODUCTION AND USE | 2013 |
|
RU2789479C2 |
| PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF | 2013 |
|
RU2663117C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS, AND A METHOD FOR USE THEREOF | 2018 |
|
RU2694226C1 |
| DRY PHARMACEUTICAL COMPOSITIONS CONTAINING NANOPARTICLES OF ACTIVE AGENT BOUND TO CARRIER PARTICLES | 2014 |
|
RU2715714C2 |
| DIRECTLY PRESSED MATRIX FOR REGULATED RELEASE OF SINGLE DAILY CLARITHROMYCIN DOSES | 2000 |
|
RU2237480C2 |
| NANOSUSPENSIONS OF NATURAL MATERIALS AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2695325C1 |
| COMPOSITE ORGANIC SUBSTANCE POWDER FOR USE IN MEDICINE, METHOD FOR PRODUCTION THEREOF AND SUSPENSION THEREOF | 2009 |
|
RU2535017C2 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION IN TREATING INFLAMMATORY EYE DISEASES AND METHOD FOR USING IT | 2012 |
|
RU2508123C1 |
